**Comparing Treatment Approaches for Knee Ligament Laxity and Torn Ligaments: Interventional Orthobiologics Versus Surgical Options – A Regenexx Perspective** Knee...

**Gene Therapy Trial Evaluates Efficacy of Cancer-Targeting Virus in Treating Brain Tumors** In the ever-evolving landscape of cancer treatment, gene...

### 2024 PRP Randomized Controlled Trial Infographic 2.0 by Regenexx: A Comprehensive Overview In the ever-evolving field of regenerative medicine,...

**Comparative Study on the Effectiveness of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: Histological and Biochemical...

**Comparative Analysis of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: A Histological and Biochemical Study –...

**Comparative Study on the Effectiveness of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: A Histological and...

**Jonathan Thomas Appointed as New President and CEO of CIRM** In a significant development for the field of regenerative medicine,...

# $53 Million Allocated for Clinical and Translational Research Funding: A Leap Forward in Medical Innovation In a significant move...

**The Role of FOXM1-Dependent Histone Linker H1B in Human Epidermal Stem Cells: Implications for Cell Death and Disease** The human...

**The Role of FOXM1-Dependent Histone Linker H1B in Human Epidermal Stem Cells: Insights from Cell Death & Disease** Human epidermal...

**Correction Notice: Influence of Thyroid Hormone Receptor β on Cancer Stem Cell Activity – Oncogene** In the ever-evolving field of...

**Nevada Approves Controversial Unproven Therapies, Joining Other States in Challenging FDA Regulations on Biologics** In a move that has sparked...

**QC Kinetix Shifts Focus from Upselling to Cost Reduction – Regenexx Reports** In the ever-evolving landscape of regenerative medicine, QC...

# Effective Approaches for Modeling Aging and Age-Related Diseases Aging is an inevitable biological process that affects all living organisms....

**Infographic on the 2024 PRP Randomized Controlled Trial by Regenexx: A Comprehensive Overview** In the ever-evolving field of regenerative medicine,...

# Semaphorin 3C (Sema3C) Modulates Stromal Microenvironment to Facilitate Hepatocellular Carcinoma Advancement – Insights from Signal Transduction and Targeted Therapy...

**Semaphorin 3C (Sema3C) Modulates Stromal Microenvironment to Facilitate Hepatocellular Carcinoma Progression – Insights from Signal Transduction and Targeted Therapy** Hepatocellular...

**Lung Institute Stem Cell Clinic Ordered to Pay $9 Million in Class Action Lawsuit Settlement** In a landmark decision, the...

# Improvement of Endothelial Function and Reduction of Portal Vein Injury with miRNA-25-3p-Expressing Mesenchymal Stem Cells – Scientific Reports ##...

**Innovative Stem Cell Therapy for Treating Cystic Fibrosis-Related Sinusitis** Cystic fibrosis (CF) is a genetic disorder that primarily affects the...

**Innovative Stem Cell Therapy for Treating Sinusitis in Cystic Fibrosis Patients** Cystic fibrosis (CF) is a genetic disorder that primarily...

**Cytosolic N-terminal Formyl-Methionine Deformylation Promotes Cancer Stem Cell Characteristics and Tumor Progression** Cancer remains one of the most formidable challenges...

**Deformylation of Cytosolic N-terminal Formyl-Methionine Promotes Cancer Stem Cell Characteristics and Tumor Progression – Scientific Reports** Cancer remains one of...

**miR-124-3p Reduces EGR1 Expression to Mitigate Ischemia-Hypoxia Reperfusion Injury in Human iPS Cell-Derived Cardiomyocytes – Scientific Reports** Ischemia-hypoxia reperfusion injury...

**miR-124-3p Suppresses Ischemia-Hypoxia Reperfusion Injury in Human iPS Cell-Derived Cardiomyocytes by Downregulating EGR1 – Scientific Reports** Ischemia-hypoxia reperfusion (IHR) injury...

**Lack of Response from FDA Commissioner Robert Califf on Stem Cell Clinics Raises Concerns** In recent years, the burgeoning field...

**Uniting the Community at the 2nd Annual ALSP Conference** In an era where legal innovation is rapidly transforming the landscape...

# Uniting the Community: Highlights from the 2nd Annual ALSP Conference The 2nd Annual Alternative Legal Service Providers (ALSP) Conference,...

# Green Synthesis of Nanohydroxyapatite Using Elaeagnus angustifolia L. Extract as a Metronidazole Nanocarrier for In Vitro Pulpitis Treatment ##...

**Influence of Prostate Pathology-Associated Plasma on Adipose-Derived Stem Cell Behavior: In Vitro Study – Scientific Reports** **Introduction** Prostate pathology, including...

“Scientific Reports: Creating an Effective Rat Duodenal Monolayer Model with Barrier Function for ADME Assays using Rat Organoids”

Scientific Reports: Creating an Effective Rat Duodenal Monolayer Model with Barrier Function for ADME Assays using Rat Organoids

Introduction:

In the field of drug discovery and development, it is crucial to assess the absorption, distribution, metabolism, and excretion (ADME) properties of potential drug candidates. One of the key aspects of ADME assays is the evaluation of drug absorption in the gastrointestinal tract. To accurately predict drug absorption in humans, it is essential to develop reliable in vitro models that mimic the physiological conditions of the human gastrointestinal tract. In recent years, organoids have emerged as a promising tool for creating such models. This article focuses on the creation of an effective rat duodenal monolayer model with barrier function for ADME assays using rat organoids.

Rat Organoids:

Organoids are three-dimensional structures derived from stem cells that self-organize and mimic the structure and function of specific organs. Rat organoids, specifically those derived from intestinal stem cells, have gained significant attention due to their ability to recapitulate the complex architecture and cellular diversity of the intestine. These organoids can be cultured in vitro and used as a model system to study various aspects of intestinal biology, including drug absorption.

Creating a Rat Duodenal Monolayer Model:

To create an effective rat duodenal monolayer model, several steps need to be followed. First, rat intestinal stem cells are isolated from the duodenum and cultured in a specialized medium that promotes their growth and differentiation into organoids. These organoids can be expanded and maintained in culture for an extended period.

Next, to generate a monolayer model, the organoids are dissociated into single cells and seeded onto a permeable membrane support. The membrane support is typically made of a porous material that allows the exchange of nutrients and gases while providing a physical barrier between the apical and basolateral compartments. The cells are then allowed to grow and differentiate on the membrane support, forming a monolayer that mimics the epithelial lining of the duodenum.

Barrier Function Assessment:

One of the critical features of an effective duodenal monolayer model is its barrier function. The monolayer should exhibit tight junctions between adjacent cells, preventing the paracellular movement of molecules. To assess the barrier function, various techniques can be employed. One commonly used method is the measurement of transepithelial electrical resistance (TEER) using a volt-ohm meter. TEER provides an indirect measure of the tightness of the monolayer, with higher resistance indicating a more intact barrier.

Another important aspect of the barrier function assessment is the evaluation of drug transport across the monolayer. This can be done by measuring the apical-to-basolateral and basolateral-to-apical transport of specific drug molecules using techniques such as liquid chromatography-mass spectrometry (LC-MS). By quantifying the drug transport, researchers can determine the permeability and efflux properties of the monolayer, providing valuable information for ADME assays.

Applications in ADME Assays:

The rat duodenal monolayer model with barrier function has significant applications in ADME assays. It can be used to assess drug absorption, metabolism, and efflux in a controlled and reproducible manner. By studying drug transport across the monolayer, researchers can gain insights into the mechanisms underlying drug absorption and identify potential drug-drug interactions or efflux transporter-mediated drug resistance.

Furthermore, this model can be utilized to evaluate the impact of various factors on drug absorption, such as pH, formulation, and co-administration with other drugs. By incorporating physiological parameters into the model, researchers can better predict drug behavior in humans and optimize drug candidates for improved bioavailability.

Conclusion:

The creation of an effective rat duodenal monolayer model with barrier function using rat organoids provides a valuable tool for ADME assays. This model allows researchers to study drug absorption in a controlled and physiologically relevant environment, providing insights into drug behavior and aiding in the development of safe and effective drugs. With further advancements in organoid technology, the potential for creating more sophisticated and accurate in vitro models for ADME assays is promising.